Martha St John, MD
Psychiatry · Houston, TXNPI 1073534921
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 311 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 311 payments — averaging $21.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$971
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$969
- Takeda Pharmaceuticals U.S.A., Inc.$649
- Otsuka America Pharmaceutical, Inc.$632
- Corium, LLC$394
- Johnson & Johnson$379
- plus $3K from 23 others
What the payments were for
- Food & beverage$6,700100%
- Education$230%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 60 | $971 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 42 | $969 |
| Takeda Pharmaceuticals U.S.A., Inc. | 34 | $649 |
| Otsuka America Pharmaceutical, Inc. | 26 | $632 |
| Corium, LLC | 16 | $394 |
| Johnson & Johnson | 15 | $379 |
| Bausch Health US, LLC | 18 | $372 |
| Lundbeck LLC | 15 | $333 |
| Alkermes, Inc. | 10 | $226 |
| Novo Nordisk | 2 | $217 |
| Noven Therapeutics, LLC | 11 | $214 |
| Axsome Therapeutics, Inc. | 6 | $161 |
| Idorsia Pharmaceuticals US Inc | 7 | $154 |
| Vanda Pharmaceuticals Inc. | 7 | $130 |
| Medtronic | 1 | $122 |
| Neos Therapeutics, LP | 6 | $109 |
| Neurocrine Biosciences, Inc. | 4 | $106 |
| E.r. Squibb & Sons, L.L.C. | 4 | $93 |
| Ironshore Pharmaceuticals Inc. | 5 | $88 |
| Supernus Pharmaceuticals, Inc. | 3 | $63 |
| Adlon Therapeutics L.p. | 3 | $61 |
| Vertical Pharmaceuticals, LLC | 3 | $47 |
| Livanova USA, Inc. | 2 | $45 |
| Avanir Pharmaceuticals, Inc. | 2 | $41 |
| Shire North American Group Inc | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Neuronetics, Inc. | 3 | $32 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Tris Pharma Inc | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$217
- SPRAVATO$123
- INTELLIS ADAPTIVESTIM$122
How this compares
$6,722 in reported general payments places this provider in the 90th percentile of 2,238 psychiatry providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ziprasidone Hcl | 16 | $3,496 |
| Bupropion XlBupropion Hcl | 41 | $1,275 |
| Duloxetine Hcl | 51 | $1,223 |
| Quetiapine Fumarate | 18 | $948 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 31 | $815 |
| Lamotrigine | 26 | $762 |
| Fluoxetine Hcl | 31 | $675 |
| Clonazepam | 103 | $646 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 21 | $586 |
| Buspirone Hcl | 22 | $414 |
| Escitalopram Oxalate | 21 | $394 |
| Paroxetine Hcl | 24 | $281 |
| Mirtazapine | 24 | $247 |
| Trazodone Hcl | 34 | $247 |
| Sertraline Hcl | 15 | $201 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Houston
- Matthew BramsHouston$1.5M
- Frank ChenHouston$941K
- Alice MaoHouston$850K
- Mazhar KhowajaHouston$843K
- Barry GritzHouston$792K
- Aaron PetersonHouston$700K
- Ayesha RashidHouston$641K
- Lawrence GinsbergHouston$502K
- Kathy FlanaganHouston$443K
- Rayan Al JurdiHouston$359K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.